Disulfiram and Cisplatin in Refractory TGCTs.

Clinical trial NCT03950830 · COMPLETED

Trial details

NCT number: NCT03950830
Sponsor: National Cancer Institute, Slovakia
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Germ Cell Tumor

Start date: 2019-05-14
Primary completion: 2021-09-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.